Leishmania, Cryptosporidium, Amoebae, Giardia, Blastocystis

  • Massimo Scaglia
  • Simonetta Gatti


Leishmaniases are endemic in 88 countries of five continents (only Australia is safe); 72 of these are distributed in tropical and subtropical areas, whereas 16 are included in the Temperate Zone [1].


Human Immunodeficiency Virus Visceral Leishmaniasis Acquire Immune Deficiency Syndrome Entamoeba Histolytica Cryptosporidium Oocyst 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Desjeux P, Piot B, O’Neill K, Meert JP (2001) Co-infections à Leishmania/VIH dans le sud de TEurope. Méd Trop 61:187–193Google Scholar
  2. 2.
    WHO (1999) Leishmaniasis co-infection, southwestern Europe, 1990-1998. Wkl Epidem Rec 74:365–376Google Scholar
  3. 3.
    Herwaldt BL (1999) Leishmaniasis. Lancet 354:1191–1199PubMedCrossRefGoogle Scholar
  4. 4.
    Hommel M (1999) Visceral leishmaniasis: biology of the parasite. J Infect 39:101–111PubMedCrossRefGoogle Scholar
  5. 5.
    Boelaert M, Criel B, Leeuwenburg J, Van Damme W, Le Ray D, Van Der Stuyft P (2000) Visceral leishmaniasis control: a public health perspective. Trans R Soc Trop Med Hyg 94:465–471PubMedCrossRefGoogle Scholar
  6. 6.
    Kafetzis DA, Maltezou HC (2002) Visceral leishmaniasis in paediatrics. Curr Opin Infect Dis 15:289–294PubMedCrossRefGoogle Scholar
  7. 7.
    Lopez-Velez R, Laguna F, Alvar J, Perez-Molina JA, Molina R, Martinez P, Villarrubia J (1995) Parasitic culture of buffy coat for diagnosis of visceral leishmaniasis in human immunodeficiency virus-infected patients. J Clin Microbiol 33:937–939PubMedGoogle Scholar
  8. 8.
    Petithory JC, Ardoin F, Ash LR, Vandemeulebroucke E, Galeazzi G, Dufour M, Paugam A (1997) Microscopic diagnosis of blood parasites following a cyto-concentration technique. Am J Trop Med Hyg 57:637–642PubMedGoogle Scholar
  9. 9.
    Pintado V, Martin-Rabadan P, Rivera ML, Moreno S, Bouza E (2001) Visceral leishmaniasis in Human Immunodeficiency Virus (HIV)-infected and non-HIV-infected patients. A comparative study. Medicine (Baltimore) 80:54–73CrossRefGoogle Scholar
  10. 10.
    Alvar J, Canavate C, Gutierrez-Solar B, Jimenez M, Laguna F, Lopez-Velez R, Molina R, Moreno J (1997) Leishmania and human immunodeficiency virus coinfection: the first 10 years. Clin Microbiol Rev 10:298–319PubMedGoogle Scholar
  11. 11.
    Pearson RD, de Queiroz Sousa A (1996) Clinical spectrum of leishmaniasis. Clin Infect Dis 22:1–13PubMedCrossRefGoogle Scholar
  12. 12.
    Jaffe CL, Grimaldi G, McMahon-Pratt D (1984) The cultivation and cloning of Leishmania. In: Morel CM (ed) Genes and antigens of parasites. A laboratory manual. Fundacao Oswaldo Cruz, Rio de Janeiro, pp 47–91Google Scholar
  13. 13.
    Garcia LS (2001) Diagnostic medical parasitology, 4th edn. ASM Press, Washington DCGoogle Scholar
  14. 14.
    Dedet JP, Pratlong F, Lambert M, Bastien P (1999) Leishmaniose et immunodepression. In: Dedet JP (ed) Les Leishmanioses. Ellipses, Paris, pp 179–190Google Scholar
  15. 15.
    Le Fichoux Y, Mary C, Marty P, Kubar J (1999) Diag nostic des Leishmanioses. In: Dedet JP (ed) Les Leishmanioses. Ellipses, Paris, pp 191–203Google Scholar
  16. 16.
    Salotra P, Sreenivas G, Pogue GP, Lee N, Nakhasi HL, Ramesh V, Negi NS (2001) Development of a species-specific PCR assay for detection of Leishmania dono-vani in clinical samples from patients with Kala-azar and post-Kala-azar dermal leishmaniasis. J Clin Microbiol 39:849–854PubMedCrossRefGoogle Scholar
  17. 17.
    Lachaud L, Chabbert E, Dubessay P, Reynes J, Lamothe J, Bastien P (2001) Comparison of various sample preparation methods for PCR diagnosis of visceral leishmaniasis using peripheral blood. J Clin Microbiol 39:613–617PubMedCrossRefGoogle Scholar
  18. 18.
    Gramiccia M, Smith DF, Angelici MC, Ready PD, Gradoni L (1992) A kinetoplast DNA probe diagnostic for Leishmania infantum. Parasitology 105:29–34PubMedCrossRefGoogle Scholar
  19. 19.
    Gradoni L, Scalone A, Gramiccia M (1993) HIV-Leishmania coinfections in Italy: serological data as indication of the sequence of acquisition of the two infections. Trans R Soc Trop Med Hyg 87:94–96PubMedCrossRefGoogle Scholar
  20. 20.
    Williams JE (1995) Leishmania and Trypanosoma. In: Gillespie SH, Hawkey PM (eds) Medical parasitology. A practical approach. IRL Press, Oxford, pp 151–176Google Scholar
  21. 21.
    Sundar S, Reed SG, Singh VP, Kumar PCK, Murray HW (1998) Rapid accurate field diagnosis of Indian visceral leishmaniasis. Lancet 351:563–565PubMedCrossRefGoogle Scholar
  22. 22.
    Marlier S, Menard G, Gisserot O, Kologo K, De Jaureguiberry JP (1999) Leishmaniose et virus del Pimmunodeficience humaine: une co-infection en emergence? Med Trop 59:193–200Google Scholar
  23. 23.
    Santos-Gomes G, Gomes-Pereira S, Campino L, De Almeida Araujo M, Abranches P (2000) Performance of immunoblotting in diagnosis of visceral leishmaniasis in human immunodeficiency virus-Leishmania sp.-coinfected patients. J. Clin Microbiol 38:175–178PubMedGoogle Scholar
  24. 24.
    Marty P, Lelievre A, Quaranta JF, Suffia I, Eulalio M, Gari-Toussaint M, Le Fichoux Y, Kubar J (1995) Detection by Western blot of four antigens characterizing acute clinical leishmaniasis due to Leishmania infantum. Trans R Soc trop Med Hyg 89:690–691PubMedCrossRefGoogle Scholar
  25. 25.
    O’Donoghue PJ (1995) Cryptosporidium and cryptosporidiosis in man and animals. Int J Parasitol 25:139–95PubMedCrossRefGoogle Scholar
  26. 26.
    Kosek KM, Alcantara C, Lima AAM, Guerrant RL (2001) Cryptosporidiosis: an update. Lancet Infecti Dis 1:262–269CrossRefGoogle Scholar
  27. 27.
    Xiao L, Morgan UM, Limor J, Escalante A, Arrowood M, Shulaw W, Thompson RC, Fayer R, Lai AA (1999) Genetic diversity within Cryptosporidium parvum and related Cryptosporidium species. Appl Environ Microbiol 65:3386–3391PubMedGoogle Scholar
  28. 28.
    Sears CL (2000) Cryptosporidium parvum: minuscule but mighty. In: Sheld WM, Craig WA, Hughes JM (eds) Emerging Infections 4. ASM Press, Washington, pp 149–163Google Scholar
  29. 29.
    Tzipori S, Widmer G (2000) The biology of Cryptosporidium. In: Petry F (ed) Cryptosporidiosis and Microsporidiosis. Karger, Basel, pp 1–32CrossRefGoogle Scholar
  30. 30.
    Hunter PR, Nichols G (2002) Epidemiology and clinical features of Cryptosporidium infection in immunocompromised patients. Clin Microbiol Rev 15:145–154PubMedCrossRefGoogle Scholar
  31. 31.
    Casemore DP (1991) Laboratory methods for diagnosis cryptosporidiosis. J Clin Pathol 44:445–451PubMedCrossRefGoogle Scholar
  32. 32.
    Current WL, Garcia LS (1991) Cryptosporidiosis. Clin Microbiol Rev 4:325–358PubMedGoogle Scholar
  33. 33.
    Current WL (1986) Cryptosporidium: its biology and potential for environmental transmission. CRC Crit Rev Envir Control 17:21–51CrossRefGoogle Scholar
  34. 34.
    Current WL, Reese NC (1986) A comparison of endogenous development of three isolates of Cryptosporidium in suckling mice. J Protozool 33:98–108PubMedGoogle Scholar
  35. 35.
    Goodgame RW, Genta RM, White AC, Chappel CL (1993) Intensity of infection in AIDS associated cryptosporidiosis. J Infect Dis 167:704–709PubMedCrossRefGoogle Scholar
  36. 36.
    Guerrant RL (1997) Cryptosporidiosis: an emerging, highly infectious threat. Emerg Infect Dis 3:51–57PubMedCrossRefGoogle Scholar
  37. 37.
    Clavel A, Arnal AC, Sanchez EC (1995) Evaluation of the optimal number of faecal specimens in the diagnosis of cryptosporidiosis in AIDS and immunocompetent patients. Eur J Clin Microbiol Infect Dis 14:46–49PubMedCrossRefGoogle Scholar
  38. 38.
    Sheather AL (1923) The detection of intestinal protozoa and mange parasites by floatation technique. J Comp Pathol Ther 36:260–275Google Scholar
  39. 39.
    Current WL, Reese NC, Ernst JV, Bailey WS, Heyman MB, Weinstein WM (1983) Human Cryptosporidium in immunocompetent and immunodeficient persons. Studies of an outbreak and experimental transmission. N Engl J Med 308:1252–1257PubMedCrossRefGoogle Scholar
  40. 40.
    Ritchie LS (1948) An ether sedimentation technique for routine stool examination. Bull US Army Med Dept 8:326Google Scholar
  41. 41.
    Pojola S (1984) Negative staining method with nigrosin for the detection of cryptosporidial oocysts. A comparative study. Res Vet Sci 36:217–219Google Scholar
  42. 42.
    Chichino G, Bruno A, Cevini C, Atzori C, Gatti S, Scaglia M (1991) New rapid staining methods of Cryptosporidium oocysts in stools. J Protozool 38:21S–21SGoogle Scholar
  43. 43.
    Elliot A, Morgan UM, Thopson A (1999) Improved staining method for detecting Cryptosporidum oocysts in stools using malachite green. J Gen Appl Microbiol 45:139–142PubMedCrossRefGoogle Scholar
  44. 44.
    Baxby D, Blundell N, Hart CA (1984) The development and performance of a simple, sensitive method for the detection of Cryptosporidium oocysts in feces. J Hyg (Cambridge) 92:317–323CrossRefGoogle Scholar
  45. 45.
    Ma P, Soave R (1983) Three-step stool examination for cryptosporidiosis in 10 homosexual men with protracted watery diarrhoea. J Infect Dis 147:824–828PubMedCrossRefGoogle Scholar
  46. 46.
    Henriksen SA, Pohlenz JFL (1981) Staining of Cryptosporidia by a modified Ziehl-Neelsen technique. Acta Vet Scand 22:594–596PubMedGoogle Scholar
  47. 47.
    Addis DG, Juranek DD, Schwartz DA (1997) Cryptosporidiosis. In: Horsburgh CR Jr, Nelson AM (eds) Pathology of emerging infections. ASM Press, Washington, pp 243–256Google Scholar
  48. 48.
    Petry F (2000) Laboratory diagnosis of Cryptosporidium parvum infection. In: Petry F (ed) Cryptosporidiosis and Microsporidiosis. Karger, Basel, PP 33–49CrossRefGoogle Scholar
  49. 49.
    Morgan UM, Pallant L, Dwyer BW, Forbes DA, Rich G, Thompson ARC (1998) Comparison of PCR and microscopy for detection of Cryptosporidium parvum in human fecal specimens: clinical trial. J Clin Microbiol 36:995–998PubMedGoogle Scholar
  50. 50.
    Ungar BL, Soave R, Fayer R, Nash TE (1986) Enzyme immunoassay detection of immunoglobulin M and G antibodies to Cryptosporidium in immunocompetent and immunocompromised persons. J Infect Dis 153:570–578PubMedCrossRefGoogle Scholar
  51. 51.
    Newman RD, Zu SX, Wuhib T, Lima AA, Guerrant RL, Sears CL (1994) Household epidemiology of Cryptosporidium parvum infection in an urban community in northeast Brazil. Ann Intern Med 120:500–505PubMedGoogle Scholar
  52. 52.
    Zu SX, Li JF, Battett LJ, Gayer R, Shu SY, McAuliffe JF, Roche JK, Guerrant RL (1994) Seroepidemiological study of Cryptosporidium infection in children from rural communities of Anhui, China and Fortaleza, Brazil. Am J Trop Med Hyg 51:1–10PubMedGoogle Scholar
  53. 53.
    Petry F (1998) Epidemiological study of Cryptosporidium parvum antibodies in sera of persons from Germany. Infection 26:7–10PubMedCrossRefGoogle Scholar
  54. 54.
    Ohnishi K, Murata M (1996) Treatment of asymptomatic amebic colitis in human immunodeficiency virus-infected persons. Int J Antimicrob Agents 7:231–233PubMedCrossRefGoogle Scholar
  55. 55.
    Brumpt E (1925) Etude sommaire de VEntamoeba dis-par n.sp., amibe 3 kystes quadrinuclees, parasite de Phomme. Bull Acad Med (Paris) 94:943–952Google Scholar
  56. 56.
    Sargeaunt PG, Williams JE (1978) Electrophoretic isoenzyme patterns of Entamoeba histolytica and Entamoeba coli. Trans R Soc Trop Med Hyg 72:164–166PubMedCrossRefGoogle Scholar
  57. 57.
    Sargeaunt PG (1992) Entamoeba histolytica is a complex of two species. Trans R Trop Med Hyg 86:348CrossRefGoogle Scholar
  58. 58.
    Tannich E, Burchard GD (1991) Differentiation of pathogenic from non-pathogenic Entamoeba histolytica by restriction fragment analysis of a single gene amplified in vitro. J Clin Microbiol 29:250–255PubMedGoogle Scholar
  59. 59.
    Acuna-Soto R, Samuelson J, De Girolami P, Zarate L, Millan-Velasco F, Schoolnick G, Wirth D (1993) Application of the polymerase chain reaction to the epidemiology of pathogenic and non-pathogenic Entamoeba histolytica. Am J Trop Med Hyg 48:58–70PubMedGoogle Scholar
  60. 60.
    Diamond LS, Clark CG (1993) A redescription of Entamoeba histolytica Schaudinn, 1903 (emended by Walker, 1911) separating it from Entamoeba dispar Brumpt, 1925. J Eukayot Microbiol 40:340–344CrossRefGoogle Scholar
  61. 61.
    Law CL, Walker J, Qassim MH (1991) Factors associated with the detection of Entamoeba histolytica in homosexual men. Int J Sex Transm Dis AIDS 2:346–350Google Scholar
  62. 62.
    Gatti S, Cevini C, Atzori C, Muratori S, Zerboni R, Cusini M, Scaglia M (1992) Non-pathogenic Entamoeba histolytica in Italian HIV-infected homosexuals. Zblt Bakt 277:382–388CrossRefGoogle Scholar
  63. 63.
    Allason-Jones E, Mindel A, Sargeaunt P, Williams P (1986) Entamoeba histolytica as a commensal intestinal parasite in homosexual men. N Engl J Med 315:353–356PubMedCrossRefGoogle Scholar
  64. 64.
    Blanshard C, Collins C, Francis N, Gazzard BG (1992) Invasive amoebic colitis in AIDS patients. AIDS 6:1043–1044PubMedCrossRefGoogle Scholar
  65. 65.
    Sturgess I, Greenfield SM, Teare J, O’Doherty MJ (1992) Ulcerative colitis developing after amoebic dysentery in a haemophiliac patient with AIDS. Gut 33:408–410PubMedCrossRefGoogle Scholar
  66. 66.
    Fätkenheuer G, Arnold G, Steffen HM, Franzen C, Schrappe M, Diehl V, Salzberger B (1997) Invasive amoebiasis in two patients with AIDS and cytomegalovirus colitis. J Clin Microbiol 35:2168–2169PubMedGoogle Scholar
  67. 67.
    Hung CC, Chen PJ, Hsieh SM, Wong JM, Fang CT, Chang SC, Chen MY (1999) Invasive amoebiasis: an emerging parasitic disease in patients infected with HIV in an area endemic for amoebic infection. AIDS 13:2421–2428PubMedCrossRefGoogle Scholar
  68. 68.
    Nozaki T (2000) Current problems of amoebiasis in Japan and recent advances in amebiasis research. Jpn J Infect Dis 53:229–237PubMedGoogle Scholar
  69. 69.
    Reed SL (2000) Clinical manifestations and diagnosis. In: Ravdin JI (ed) Amebiasis. Imperial College Press, London, pp 113–126CrossRefGoogle Scholar
  70. 70.
    Haque R, Neville LM, Hahn P, Petri WA Jr (1995) Rapid diagnosis of Entamoeba infection by using Entamoeba and Entamoeba histolytica stool antigen detection kits. J Clin Microbiol 33:2558–2561PubMedGoogle Scholar
  71. 71.
    Scaglia M, Cevini C, Bruno A, Novati S, Gatti S (1995) Transmission of Entamoeba histolytica within a family complex. Trans R Soc Trop Med Hyg 89:403–405PubMedCrossRefGoogle Scholar
  72. 72.
    Petithory JC, Ardoin-Guidon F, Chaumeil C (1998) Amibes et flagelles intestinaux. Amibes oculaires. Leur diagnostic microscopique. Cahier de Formation en Biologie medicale. Bioforma, ParisGoogle Scholar
  73. 73.
    Robinson GL (1968) The laboratory diagnosis of human parasitic amoebae. Trans R Soc Trop Med Hyg 62:285–294PubMedCrossRefGoogle Scholar
  74. 74.
    Irusen EM, Jackson TFGH, Simjee AE (1992) Asymptomatic intestinal colonization by pathogenic Entamoeba histolytica in amebic liver abscess: prevalence, response to therapy and pathogenic potential. Clin Infect Dis 14:889–893PubMedCrossRefGoogle Scholar
  75. 75.
    Ravdin JI (2000) Entamoeba histolytica (Amebiasis). In: Mandell GL, Bennett JE, Dolin R (eds) Principles and practice of infectious diseases. Churchill Livingstone, Philadelphia, pp 2798–2810Google Scholar
  76. 76.
    Sargeaunt PG (1988) Zymodemes of Entamoeba histolytica. In: Ravdin JI (ed) Amebiasis. Human infection by Entamoeba histolytica. Churchill Livingstone, New York, pp 370–387Google Scholar
  77. 77.
    Mirelman D, Nuchamowitz Y, Stolarsku T (1997) Comparison of use of enzyme-linked immunosorbent assay-based kits and PCR amplification of rRNA genes for simultaneous detection of Entamoeba histolytica and Entamoeba dispar. J Clin Microbiol 35:2405–2407PubMedGoogle Scholar
  78. 78.
    Haque R, Moliah NV, Ali IKM, Alam K, Eubanks A, Lyerly D, Petri WA Jr (2000) Diagnosis of amebic liver abscess and intestinal infection with the TechLab Entamoeba histolytica II antigen detection and antibody tests. J Clin Microbiol 38:3235–3239PubMedGoogle Scholar
  79. 79.
    Pillai DR, Keystone JS, Sheppard CD, MacLean JD, MacPherson DW, Kain KC (1999) Entamoeba histolytica and Entamoeba dispar: epidemiology and comparison of diagnostic methods in a setting of nonendemicity. Clin Infect Dis 29:1315–1318PubMedCrossRefGoogle Scholar
  80. 80.
    Gatti S, Swierczynski G, Robinson F, Anselmi M, Corraled J, Moreira J, Montalvo G, Bruno A, Maserati R, Bisoffi Z, Scaglia M (2002) Amebic infections due to Entamoeba histolytica-Entamoeba dispar complex. A study of the incidence in a remote rural area of Ecuador. Am J Trop Med Hyg 67:123–127PubMedGoogle Scholar
  81. 81.
    Jackson TFGH (2000) Epidemiology. In: Ravdin JI (ed) Amebiasis. Imperial College Press, London, PP 47–63CrossRefGoogle Scholar
  82. 82.
    Novati S, Sironi M, Granata S, Bruno A, Gatti S, Scaglia M, Bandi C (1996) Direct sequencing of the PCR amplified SSU rRNA gene of Entamoeba dispar and the design of primers for rapid differentiation from Entamoeba histolytica. Parasitology 112:363–369PubMedCrossRefGoogle Scholar
  83. 83.
    Tanyuksel M, Tachibana H, Petri WA Jr (2000) Amebiasis, an emerging disease. In: Sheld WM, Craig WA, Hughes JM (eds) Emerging infections 5. ASM Press, Washington, DC, pp 197–212Google Scholar
  84. 84.
    Rondanelli EG, Scaglia M (1993) Atlas of human protozoa. Masson, MilanoGoogle Scholar
  85. 85.
    Martinez-Palomo A, Espinosa Cantellano M (1998) Intestinal amoebae. In: Cox FEG, Kreier JP, Wakelin D (eds) Topley & Wilson’s. Microbiology and microbial infections. Arnold, London, pp 157–177Google Scholar
  86. 86.
    Scaglia M (1997) Patologia umana da amebe a vita libera. Ann 1st Sup Sanitá 33:551–566Google Scholar
  87. 87.
    Visvesvara GS, Neafie RC, Martinez AJ (1997) Pathogenic and opportunistic free-living amebae. In: Hors-burgh CR, Nelson AM (eds) Pathology of emerging infections. ASM Press, Washington, pp 257–267Google Scholar
  88. 88.
    Martinez AJ, Visvesvara GS (1997) Free-living, amphizoic and opportunistic amebas. Brain Pathol 7:583–598PubMedCrossRefGoogle Scholar
  89. 89.
    Sison JP, Kemper CA, Loveless M, McSchane D, Visvesvara GS, Deresinki SC (1995) Disseminated Acanthamoeba infection in patients with AIDS: case reports and review. Clin Infect Dis 20:1207–1216PubMedCrossRefGoogle Scholar
  90. 90.
    Torno MS, Babapour R, Gurevitch A, Witt MD (2000) Cutaneous acanthamoebiasis in AIDS. J Am Acad Dermatol 42:351–354PubMedCrossRefGoogle Scholar
  91. 91.
    Martinez AJ, Visvesvara GS (2001) Balamuthia mandrillaris infection. J Med Microbiol 50:205–207PubMedGoogle Scholar
  92. 92.
    Visvesvara GS, Schuster FL, Martinez AJ (1993) Balamuthia mandrillaris,N.G., N.Sp. agent of amebic meningoencephalitis in humans ans other animals. J Eukaryot Microbiol 40:504–514PubMedCrossRefGoogle Scholar
  93. 93.
    De Jonckheere J (1977) Use of axenic medium for differentiation between pathogenic and nonpathogenic Naegleria fowleri isolates. Appl Environ Microbiol 33:751–757PubMedGoogle Scholar
  94. 94.
    Haight JB, John DT (1980) Growth of Naegleria fowleri in several axenic media. Folia Parasitol 27:207–212PubMedGoogle Scholar
  95. 95.
    Visvesvara GS (1987) Laboratory diagnosis. In: Rondanelli EG (ed) Amphizoic amoebae. Human pathology. Piccin, Padova, pp 193–215Google Scholar
  96. 96.
    Schuster FL, Rechthand E (1975) In vitro effect of amphotericin B on growth and ultrastructure of the ameboflagellates Naegleria gruberi and Naegleria fowleri. Antimicrob Agents Chemother 8:591–605PubMedCrossRefGoogle Scholar
  97. 97.
    Ferrante A, Abell TJ, Robinson B, Loderer E (1987) Effects of sinefungin and difluoromethylornithine on pathogenic free-living amoebae in vitro. FEMS Microbiol Lett 40:67–70CrossRefGoogle Scholar
  98. 98.
    Schuster FL, Jacob LS (1992) Effects of maiganins on ameba and cyst stages of Acanthamoeba polyphaga. Antimicrob Agents Chemother 8:1263–1271CrossRefGoogle Scholar
  99. 99.
    Gatti S, Cevini C, Bruno A, Penso G, Rama P, Scaglia M (1998) In vitro effectiveness of Povidone-Iodine on Acanthamoeba isolates from human cornea. Antimicrob Agents Chemother 42:2232–2234PubMedGoogle Scholar
  100. 100.
    Schuster FL, Visvesvara GS (1996) Axenic growth and drug sensitivity studies of Balamuthia mandrillaris, an agent of amebic meningoencephalitis in humans and other animals. J Clin Microbiol 34:385–388PubMedGoogle Scholar
  101. 101.
    Moura H, Wallace S, Visvesvara GS (1992) Acanthamoeba healyi, N.sp. and the isoenzyme and immunoblot profiles of Acanthamoeba spp., group 1 and 3. J Parasitol 39:573–583Google Scholar
  102. 102.
    Pernin P, Hullo A, Omar S, Pussard MM (1992) Keratite amibienne ä Acanthamoeba. Etude mor-phologique et isoenzymatique d’une souche isolee d’un cas traite medicalement. Bull Soc Path Ex 85:226–231Google Scholar
  103. 103.
    Vodkin MH, Howe DK, Visvesvara GS, McLaughlin GC (1992) Identification of Acanthamoeba at the generic and specific levels using the polymerase chain reaction. J Protozool 39:378–385PubMedGoogle Scholar
  104. 104.
    Stothard DR, Schroeder-Dietrich JM, Awwad MH, Gast RJ, Ledee DR, Rodriguez-Zaragoza S, Dean CL, Fuerst PA, Byers TJ (1998) The evolutionary history of the genus Acanthamoeba and the identification of eight new 18S rRNA gene sequence types. J Eukaryot Microbiol 45:45–54PubMedCrossRefGoogle Scholar
  105. 105.
    Walochnik J, Obwaller A, Aspöck H (2000) Correlations between morphological, molecular, biological, and physiological characteristics in clinical and non clinical isolates of Acanthamoeba spp. Appl Environ Microbiol 66:4408–4413PubMedCrossRefGoogle Scholar
  106. 106.
    Schroeder JM, Booton GC, Hay J, Niszl IA, Seal DV, Markus MB, Fuerst PA, Byers TJ (2001) Use of subgenic 18S ribosomal DNA PCR and sequencing for genus and genotype identification of acanthamoebae from humans with keratitis and from sewage sludge. J Clin Microbiol 39:1903–1911PubMedCrossRefGoogle Scholar
  107. 107.
    Martinez AJ, Scaglia M (1987) Experimental infections (animal model). In: Rondanelli EG (ed) Amphizoic amoebae. Human pathology. Piccin, Padova, pp 240–246Google Scholar
  108. 108.
    Janitschke K, Martinez AJ, Visvesvara GS, Schuster F (1996) Animal model Balamuthia mandrillaris CNS infection: contrast and comparison in immunodefi-cient and immunocompetent mice. A murine model of “granulomatous” amebic encephalitis. J Neuropathol Exp Neurol 55:815–821PubMedCrossRefGoogle Scholar
  109. 109.
    Barwick RS, Levy DA, Braun GF, Beach HJ, Calderon RL (2000) Surveillance for water-borne disease outbreaks. United States, 1997-1998. MMWR CDC Surveill Summ 49[SS-4]:136Google Scholar
  110. 110.
    Adam RD (2001) Biology of Giardia lamblia. Clin Microbiol Rev 14:447–475PubMedCrossRefGoogle Scholar
  111. 111.
    Ortega YR, Adam RD (1997) Giardia: overview and update. Clin Infect Dis 25:545–550PubMedCrossRefGoogle Scholar
  112. 112.
    Wolfe MS (1992) Giardiasis. Clin Microbiol Rev 5:93–100PubMedGoogle Scholar
  113. 113.
    Mahmoud AAF (1998) ”New” intestinal parasitic pro tozoa. In: Krause RM (ed) Emerging infections. Academic Press, San Diego London Boston New York Sydney Tokyo Toronto, pp 431–445CrossRefGoogle Scholar
  114. 114.
    Isaac-Renton JL (1991) Laboratory diagnosis of giardiasis. Clin Lab Med 11:811–827PubMedGoogle Scholar
  115. 115.
    Erlandsen SL, Macechko PT, van Keulen H, Jarroll EL (1996) Formation of the Giardia cyst wall: studies on extracellular assembly using immunogold labelling and high resolution field emission SEM. J Eukaryot Microbiol 43:416–429PubMedCrossRefGoogle Scholar
  116. 116.
    Garcia LS, Bruckner DA (1997) Diagnostic medical parasitology, 3rd edn. ASM Press, Washington CDGoogle Scholar
  117. 117.
    Smith HV (1995) Intestinal protozoa. In: Gillespie SH, Hawkey PM (eds) Medical parasitology. A practical approach. IRL Press, Oxford New York Tokyo, pp 79–118Google Scholar
  118. 118.
    Gardner TB, Hill DR (2001) Treatment of giardiasis. Clin Microbiol Rev 14:114–128PubMedCrossRefGoogle Scholar
  119. 119.
    Pillai DR, Kain KC (1999) Immunochromatographic strip-based detection of Entamoeba histolytica-E.dispar and Giardia lamblia cop?o antigen. J Clin Microbiol 37:3017–3019PubMedGoogle Scholar
  120. 120.
    Garcia LS, Shimizu RY, Bernard CN (2000) Detection of Giardia lamblia, Entamoeba histolytica/E. dispar, and Cryptosporidium parvum antigens in human fecal specimens using the Triage parasite panel enzyme immunoassay. J Clin Microbiol 38:3337–3340PubMedGoogle Scholar
  121. 121.
    Sharp SE, Suarez CA, Duran Y, Poppiti RJ (2001) Evaluation of the Triage microparasite panel for detection of Giardia lamblia. Entamoeba histolytica/Entamoeba dispar, and Cryptosporidium parvum in patient stool specimens. J Clin Microbiol 39:332–334PubMedCrossRefGoogle Scholar
  122. 122.
    Mathis A, Deplazes P, Kohler P, Eckert J (1996) PCR for detection and characterization of parasites (Leishmania, Echinococcus, Microsporidia, Giardia). Schweiz Arch Tierheilkd 138:133–138PubMedGoogle Scholar
  123. 123.
    Homan WL, Gilsing M, Bentala H, Limper L, van Knapen F (1998) Characterization of Giardia duode-nalis by polymerase-chain-reaction fingerprinting. Parasitol Res 84:707–714PubMedCrossRefGoogle Scholar
  124. 124.
    Ghosh S, Debnath A, Sil A, De S, Chattopadhyay DJ, Das P (2000) PCR detection of Giardia lamblia in stool: targeting intergenic spacer region of multicopy rRNA gene. Mol Cell Probes 14:181–189PubMedCrossRefGoogle Scholar
  125. 125.
    Zierdt CH (1991) Blastocystis hominis. Past and future. Clin Microbiol Rev 4:61–79PubMedGoogle Scholar
  126. 126.
    Stenzel DJ, Boreham PFL (1996) Blastocystis hominis revisited. Clin Microbiol Rev 9:563–584PubMedGoogle Scholar
  127. 127.
    Zierdt CH, Zierdt WS, Nagy B (1995) Enzyme-linked immunosorbent assay for detection of serum antibody to Blastocystis hominis infections. J Parasitol 81:127–129PubMedCrossRefGoogle Scholar
  128. 128.
    Chen J, Vaudry WL, Kowalewska K, Wenman WM (1987) Lack of serum immune response to Blastocystis hominis (letter). Lancet 1:1021CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2003

Authors and Affiliations

  • Massimo Scaglia
  • Simonetta Gatti

There are no affiliations available

Personalised recommendations